Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations (Q35201288)

7 August 2017

Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations (English)

1 reference

7 August 2017

1 reference

amiodarone

15 June 2024

Louise Pilote

10

0 references

Jack V. Tu

object named as

Jack V Tu

7

0 references

author name string

Meytal A Tsadok

1

1 reference

7 August 2017

Cynthia A Jackevicius

2

1 reference

7 August 2017

Elham Rahme

3

1 reference

7 August 2017

Vidal Essebag

4

1 reference

7 August 2017

Mark J Eisenberg

5

1 reference

7 August 2017

Karin H Humphries

6

1 reference

7 August 2017

Hassan Behlouli

8

1 reference

7 August 2017

Jennifer Joo

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

11 July 2011

1 reference

Canadian Medical Association Journal

7 August 2017

1 reference

7 August 2017

183

1 reference

7 August 2017

12

1 reference

7 August 2017

E817-23

1 reference

Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Rhythm control agents and adverse events in patients with atrial fibrillation.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

13 July 2018

Amiodarone and thyroid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Effects of amiodarone therapy on thyroid function

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Formulation substitution: a frequently overlooked variable in cardiovascular drug management

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

13 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

13 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

The effects of amiodarone on the thyroid

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Issues in the use of generic antiarrhythmic drugs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Pharmaceutical policies in Canada: another example of federal-provincial discord

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Generic antiarrhythmic drugs: what constitutes equivalency

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

How frequently should a patient taking amiodarone be screened for thyroid dysfunction?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Comparison of plasma concentrations for two amiodarone products

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Effects of severity of chronic obstructive pulmonary disease on thyroid function.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Altered metabolite concentrations with amiodarone generic substitution cannot be observed without monitoring

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168665

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

26 September 2018

1 reference

12 December 2020

Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias

1 reference

12 December 2020

Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism

1 reference

12 December 2020

Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide

1 reference

12 December 2020

Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals

1 reference

12 December 2020

Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease

1 reference

12 December 2020

Use of the CHADS2 risk score to guide antithrombotic treatment in patients with atrial fibrillation--room for improvement

1 reference

12 December 2020

Identifiers

DOI

10.1503/CMAJ.101800

1 reference

7 August 2017

1 reference

7 August 2017

1 reference